Ionis Pharmaceuticals Announces License Agreement With Recordati For Zilganersen In Alexander Disease In All Countries Outside The US For $30M Upfront Payment

Loading news article.

Ionis Pharmaceuticals Announces License Agreement With Recordati For Zilganersen In Alexander Disease In All Countries Outside The US For $30M Upfront Payment | WAPE

Ionis Pharmaceuticals Announces License Agreement With Recordati For Zilganersen In Alexander Disease In All Countries Outside The US For $30M Upfront Payment

Article summary

Related companies

Comments —